Literature DB >> 2355241

Cause of death among patients with Parkinson's disease: a rare mortality due to cerebral haemorrhage.

S Iwasaki1, Y Narabayashi, K Hamaguchi, A Iwasaki, M Takakusagi.   

Abstract

Causes of death, with special reference to cerebral haemorrhage, among 240 patients with pathologically verified Parkinson's disease were investigated using the Annuals of the Pathological Autopsy Cases in Japan from 1981 to 1985. The leading causes of death were pneumonia and bronchitis (44.1%), malignant neoplasms (11.6%), heart diseases (4.1%), cerebral infarction (3.7%) and septicaemia (3.3%). Cerebral haemorrhage was the 11th most frequent cause of death, accounting for only 0.8% of deaths among the patients, whereas it was the 5th most common cause of death among the Japanese general population in 1985. The low incidence of cerebral haemorrhage as a cause of death in patients with Parkinson's disease may reflect the hypotensive effect of levodopa and a hypotensive mechanism due to reduced noradrenaline levels in the parkinsonian brain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2355241     DOI: 10.1007/bf00314665

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Arterial blood pressure in patients with Parkinson's disease.

Authors:  M J Aminoff; M Gross; B Laatz; S D Vakil; A Petrie; D B Calne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-01       Impact factor: 10.154

2.  Pergolide: a potent dopaminergic antihypertensive.

Authors:  T T Yen; N B Stamm; J A Clemens
Journal:  Life Sci       Date:  1979-07-16       Impact factor: 5.037

3.  Treatment of parkinsonism with levodopa.

Authors:  M D Yahr; R C Duvoisin; M J Schear; R E Barrett; M M Hoehn
Journal:  Arch Neurol       Date:  1969-10

4.  Mortality of patients with Parkinson's disease treated with levodopa.

Authors:  R J Marttila; U K Rinne; T Siirtola; V Sonninen
Journal:  J Neurol       Date:  1977-10-07       Impact factor: 4.849

5.  Letter: Bromocriptine and hypertension.

Authors:  S B Kaye; K M Shaw; E J Ross
Journal:  Lancet       Date:  1976-05-29       Impact factor: 79.321

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Brain dopamine depletion by lesions in the substantia nigra attenuates the development of hypertension in the spontaneously hypertensive rat.

Authors:  M van den Buuse; D H Versteeg; W de Jong
Journal:  Brain Res       Date:  1986-03-12       Impact factor: 3.252

8.  Parkinsonism treated with levodopa: progression and mortality.

Authors:  M M Maier Hoehn
Journal:  J Neural Transm Suppl       Date:  1983

9.  Reduction in blood pressure in normal and spontaneously hypertensive rats by lergotrile mesylate.

Authors:  A F Sved; J D Fernstrom
Journal:  J Pharm Pharmacol       Date:  1979-12       Impact factor: 3.765

10.  Hypotension caused by L-dopa.

Authors:  D B Calne; J Brennan; A S Spiers; G M Stern
Journal:  Br Med J       Date:  1970-02-21
View more
  4 in total

1.  Parkinson's disease and cerebrovascular disease: is there a link? A neurosonological case-control study.

Authors:  Sandro Zambito Marsala; Manuela Gioulis; Michele Pistacchi; Cecilia Lo Cascio
Journal:  Neurol Sci       Date:  2016-07-09       Impact factor: 3.307

Review 2.  From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue.

Authors:  Donovan Tucker; Yujiao Lu; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2017-08-24       Impact factor: 5.590

Review 3.  Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord       Date:  2018-03       Impact factor: 10.338

Review 4.  Abnormal neural oscillations during gait and dual-task in Parkinson's disease.

Authors:  Rachel O Nwogo; Stefan Kammermeier; Arun Singh
Journal:  Front Syst Neurosci       Date:  2022-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.